ACE and colorectal cancer: Whilst a large, retrospective, cohort study of 1,693,297 people (cases=28,460) found no evidence for an association of cumulative duration of ACE inhibitor use with colorectal cancer risk (HR: 1.03, 95% CI: 0.99, 1.07) (40).